Name | Synonyms | Targets | Target Pathway | PubCHEM | Datatset | Sample size | Screening site |
---|---|---|---|---|---|---|---|
Alisertib | MLN8237 | AURKA | Mitosis | GDSC1 | 891 | MGH | |
Alisertib | MLN8237 | AURKA | Mitosis | 24771867 | GDSC2 | 949 | SANGER |
Idelalisib | CAL-101, Zydelig | PI3Kdelta | PI3K/MTOR signaling | 11625818 | GDSC1 | 914 | MGH |
Lenalidomide | CDC-501, CC-5013, Revlimid | CRBN | Protein stability and degradation | 216326 | GDSC1 | 933 | SANGER |
Lenalidomide | CDC-501, CC-5013, Revlimid | CRBN | Protein stability and degradation | 216326 | GDSC2 | 949 | SANGER |
Omipalisib | GSK2126458, GSK-2126458, EX-8678, GSK458 | PI3K (class 1), MTORC1, MTORC2 | PI3K/MTOR signaling | 25167777 | GDSC1 | 914 | MGH |
Oxaliplatin | Eloxatin | DNA alkylating agent | DNA replication | 5310940 | GDSC2 | 967 | SANGER |
Oxaliplatin | DNA alkylating agent | DNA replication | GDSC2 | 717 | SANGER | ||
Pilaralisib | XL-147 | PI3K | PI3K/MTOR signaling | GDSC1 | 919 | MGH | |
Tretinoin | ATRA, Vesanoid, Renova, Atralin, Tretin-X, Avita | Retinoic acid | Other | 444795 | GDSC1 | 923 | SANGER |
Tretinoin | ATRA, Vesanoid, Renova, Atralin, Tretin-X, Avita | Retinoic acid | Other | 444795 | GDSC2 | 225 | SANGER |
Voxtalisib | XL-765, SAR245409 | PI3K (class 1), DNAPK, MTOR | PI3K/MTOR signaling | GDSC1 | 919 | MGH |
Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.